BIOMAT Database Logo BIOMAT Database Logo

Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agents. 2009

Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA. wangd@wyeth.com

Checkpoint deficiency of malignant cells can be exploited in cancer drug discovery. Compounds that selectively kill checkpoint-deficient cells versus checkpoint-proficient cells can be utilized to preferentially target tumor cells, while sparing normal cells. The protein p21(Wafl/Cipl/Sdi1) (hereafter referred to as p21) inhibits progression of the cell cycle by inhibiting the activity of G1 kinases (cyclin D/cdk4 and cyclin E-cdk2) and the G2 kinase (cyclin B/cdkl) in response to DNA damage or abnormal DNA content. The expression of p21 is often low in human cancer cells due to frequent loss of the upstream activator, p53, and is associated with poor prognosis in some cancer patients. Using an isogenic pair of cell lines, HCT116 (p21+/+) and 80S14 (p21-/-), we have disclosed previously a novel series of pyrazolo[1,5-a]pyrimidines that preferentially kill the p21-deficient cells. We will present the synthesis, biological activities and SAR study of a series of pyrazolo[1,5-a]pyrimidines with an optimized phenyl amide moiety at the C-7 position. The mechanism of action of these compounds will also be discussed.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel anti-proliferative agents: parallel synthesis for lead optimization of amide region.
March 2005, Bioorganic & medicinal chemistry letters,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel antiproliferative agents: exploration of core and headpiece structure-activity relationships.
March 2007, Bioorganic & medicinal chemistry letters,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
N-(2-Bromo-4-methyl-phen-yl)-2-(5-methyl-2-phenyl-pyrazolo-[1,5-a]pyrimidin-7-yl)acetamide.
June 2013, Acta crystallographica. Section E, Structure reports online,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
March 2011, European journal of medicinal chemistry,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
July 2015, ACS medicinal chemistry letters,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo[1,5-a]pyrimidines as novel larotrectinib analogs.
January 2020, Bioorganic chemistry,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Structure-Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents.
February 2021, ACS infectious diseases,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Novel Pyrazolo[3,4-d]pyrimidin-4-one Derivatives as Potential Antifungal Agents: Design, Synthesis, and Biological Evaluation.
September 2021, Journal of agricultural and food chemistry,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands.
March 2017, Bioorganic & medicinal chemistry,
Yanong D Wang, and Erick Honores, and Biqi Wu, and Steve Johnson, and Dennis Powell, and Miriam Miranda, and John P McGinnis, and Carolyn Discafani, and Sridhar K Rabindran, and Wendy Cheng, and Girija Krishnamurthy
Synthesis and biological evaluation of chalcone-linked pyrazolo[1,5-a]pyrimidines as potential anticancer agents.
September 2017, MedChemComm,
Copied contents to your clipboard!